北京大学学报(医学版) ›› 2024, Vol. 56 ›› Issue (4): 693-699. doi: 10.19723/j.issn.1671-167X.2024.04.024

• 论著 • 上一篇    下一篇

健康体检人群血尿酸与气流阻塞的相关性

周庆欣,杨晴晴,石舒原,李沛,孙凤*()   

  1. 北京大学公共卫生学院流行病与卫生统计学系, 北京 100191
  • 收稿日期:2021-02-23 出版日期:2024-08-18 发布日期:2024-07-23
  • 通讯作者: 孙凤 E-mail:sunfeng@bjmu.edu.cn

Association between serum uric acid and airflow obstruction based on the health-checkup population

Qingxin ZHOU,Qingqing YANG,Shuyuan SHI,Pei LI,Feng SUN*()   

  1. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
  • Received:2021-02-23 Online:2024-08-18 Published:2024-07-23
  • Contact: Feng SUN E-mail:sunfeng@bjmu.edu.cn

RICH HTML

  

摘要:

目的: 探讨中国台湾健康体检人群中血尿酸水平与肺功能指标和气流阻塞之间的相关性。方法: 利用中国台湾美兆健康资源中心的体检资料,选取于1996—2016年间进行体检的40岁以上人群进行横断面分析,按照性别分别进行血尿酸水平与肺功能指标的相关性分析,以及血尿酸水平对气流阻塞影响的Logistic回归分析。结果: 共纳入35 465人,平均年龄(45.70±7.30)岁,男性16 411人,女性19 054人,其中,男性的血尿酸水平高于女性,存在气流阻塞的人群血尿酸水平高于无气流阻塞的人群。女性血尿酸水平与肺功能指标[第一秒用力呼气容积(forced expiratory volume in one second, FEV1)、用力肺活量(force vital capacity, FVC)]之间呈负相关(P<0.05),男性血尿酸水平与肺功能指标FEV1、FVC之间则无显著相关性(P>0.05)。在调整年龄、教育程度、吸烟、饮酒、工作强度、体重指数、是否咳嗽、高血压病史、糖尿病病史等指标,以及白细胞、白蛋白等生化指标后,随着血尿酸浓度的升高,女性更易存在气流阻塞(OR=1.12,95%CI: 1.02~1.22,P<0.05)。按照是否患高尿酸血症进行分组,结果显示与血尿酸正常组相比,女性中高尿酸血症组更易存在气流阻塞(OR=1.36,95%CI: 1.06~1.75,P<0.05),而男性中血尿酸浓度与气流阻塞患病之间无显著相关性(OR=1.04,95%CI: 0.96~1.13,P>0.05),是否患高尿酸血症与气流阻塞的存在无显著相关性(OR=1.12,95%CI: 0.89~1.39,P>0.05)。结论: 女性健康体检人群中,血尿酸水平与肺功能指标FEV1、FVC之间存在负相关,高尿酸血症与气流阻塞的存在有相关性,在男性中则不明显。未来仍需要前瞻性研究来进一步验证高血尿酸水平是否与气流阻塞的发生相关联。

关键词: 尿酸, 呼吸功能试验, 慢性阻塞性肺疾病, 横断面研究

Abstract:

Objective: To investigate the association between serum uric acid, pulmonary function and airflow obstruction in Chinese Taiwan healthy subjects. Methods: All the cross-sectional analysis was performed in the population over 40 years old using the physical examination data of Chinese Taiwan MJ Health Resource Center between 1996 and 2016 stratification by gender. The correlation analyses between serum uric acid were done and multivariate Logistic regression analysis was used to explore the effect of serum uric acid on airflow obstruction. Results: A total of 35 465 people were included in the study, including 16 411 men and 19 054 women. Among them, the serum uric acid concentration of men was higher than that of women, and the serum uric acid concentration of the people with airflow obstruction was higher than that of the people without airflow obstruction. There was a negative correlation between serum uric acid level and the forced expiratory volume in one second (FEV1) and the force vital capacity (FVC) in women (P < 0.05), but in men the correlation didn' t exist (P>0.05). After adjusting for age, education, smoking status, drinking status, work strength, body mass index, history of cough, history of hypertension, history of diabetes, history of dyslipidemia, white blood cells and blood albumin, the airflow obstruction in women was more likely to exist with the serum uric acid elevated (OR=1. 12, 95%CI: 1.02-1.22, P < 0.05). The results showed that women with hyperuricemia were more likely to have airflow obstruction than those without hyperuricemia (OR=1.36, 95%CI: 1.06-1.75, P < 0.05). There was no correlation between serum uric acid concentration and airflow obstruction in men (OR=1.04, 95%CI: 0.96-1.13, P>0.05), also the hyperuricemia and airflow obstruction (OR=1.12, 95%CI: 0.89-1.39, P>0.05). Conclusion: There is a negative correlation between serum uric acid and FEV1 and FVC in relatively healthy women, and there is an association between elevated serum uric acid and airflow obstruction in women, but not in men. Further prospective studies are needed to explore whether high serum uric acid level can increase the risk of airflow obstruction.

Key words: Uric acid, Respiratory function tests, Chronic obstructive pulmonary disease, Cross-sectional study

中图分类号: 

  • R181.3

表1

研究人群基线特征"

ItemsMen Women
Normal group (n=15 905) Airflow obstruction group(n=506) P value Normal group(n=18 536) Airflow obstruction group(n=518) P value
Age/years 45.40±7.37 51.50±9.56 <0.001 45.60±7.02 50.90±8.52 <0.001
Marriage status 0.002 <0.001
  Unmarried 626 (4.14) 11 (2.26) 1 124 (6.41) 15 (3.02)
  Married 14 035 (92.70) 448 (92.20) 14 657 (83.60) 403 (81.20)
  Divorce/widowed 478 (3.16) 27 (5.56) 1 744 (9.95) 78 (15.70)
Education <0.001 <0.001
  High school and below 5 743 (37.20) 305 (61.90) 9 786 (54.40) 390 (77.20)
  High school and above 9 700 (62.80) 188 (38.10) 8 217 (45.60) 115 (22.80)
Smoking status 0.001 0.203
  Never 8 099 (52.80) 205 (44.00) 16 558 (95.10) 431 (96.60)
  Passive smoking 1 853 (12.10) 69 (14.80) 167 (0.96) 1 (0.22)
  Current smoking 5 380 (35.10) 192 (41.20) 690 (3.96) 14 (3.14)
Working strength <0.001 0.007
  Mild 9 128 (59.80) 233 (50.70) 11 598 (65.60) 277 (58.30)
  Moderate 3 783 (24.80) 120 (26.10) 4 790 (27.10) 159 (33.50)
  Severe 1 847 (12.10) 82 (17.80) 1 169 (6.61) 34 (7.16)
  Extremely severe 494 (3.24) 25 (5.43) 127 (0.72) 5 (1.05)
Hypertension 3 137 (19.70) 142 (28.10) <0.001 2 528 (13.60) 118 (22.80) <0.001
Diabetes 771 (4.85) 37 (7.31) 0.016 530 (2.86) 26 (5.02) 0.006
Hyperlipidemia 11 733 (73.80) 384 (75.90) 0.309 9 547 (51.50) 341 (65.80) <0.001
Obesity 5 992 (37.70) 175 (34.60) 0.172 3 800 (20.50) 151 (29.20) <0.001
Frequent cough 1 669 (11.40) 85 (19.30) <0.001 1 528 (8.91) 75 (16.40) <0.001
FEV1/L 3.54±0.40 3.29±0.44 <0.001 2.58±0.28 2.39±0.29 <0.001
FVC/L 4.32±0.48 4.05±0.50 <0.001 3.15±0.32 2.95±0.32 0.123
WBC/(×103/μL) 6.38±1.63 6.73±1.65 <0.001 5.85±1.51 6.17±1.46 <0.001
FBG/(mg/dL) 102±19.40 103±25.90 0.527 97.00±16.90 98.70±23.50 0.098
HDLC/(mg/dL) 47.9±12.50 46.30±13.40 0.009 59.40±15.40 55.20±15.40 <0.001
LDLC/(mg/dL) 127±32.00 130±34.60 0.133 117±32.00 127±32.90 <0.001
GFR/[mL/(min·1.73 m2)] 82.40±12.90 78.30±13.10 <0.001 87.70±14.60 83.90±14.80 <0.001
Triglycerides/(mg/dL) 145.00±99.60 136.00±87.00 0.025 98.70±66.00 113.00±78.90 <0.001
Albumin/(g/dL) 4.54±0.24 4.59±0.28 <0.001 4.42±0.24 4.50±0.26 <0.001
ALT/(IU/L) 24.80±12.70 24.60±9.94 0.704 21.00±16.90 23.10±25.40 0.070
AST/(IU/L) 32.40±26.00 29.10±17.80 <0.001 20.60±26.20 22.90±30.60 0.087
Creatinine/(mg/dL) 1.08±0.15 1.10±0.16 0.009 0.81±0.12 0.83±0.13 0.001
Serum uric acid/(mg/dL) 6.65±1.30 6.76±1.43 0.065 4.93±1.20 5.35±1.40 <0.001
Hyperuricemia 5 660 (35.60) 207 (40.90) 0.016 2 954 (15.90) 147 (28.40) <0.001
Kidney injury 1 267 (7.97) 62 (12.30) 0.001 999 (5.39) 44 (8.49) 0.003

图1

肺功能指标FEV1和FVC与血尿酸之间的相关性"

表2

血尿酸和高尿酸血症与气流阻塞发生的Logistic回归分析"

ItemsModel 1 Model 2 Model 3 Model 4 Model 5
OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value
Men
  Serum uric acid 1.07 (1.00-1.15) 0.040 1.05 (0.98-1.13) 0.158 1.06 (0.98-1.15) 0.160 1.07 (0.98-1.16) 0.120 1.04 (0.96-1.13) 0.305
  Hyperuricemia 1.23 (1.03-1.48) 0.025 1.16 (0.95-1.42) 0.158 1.15 (0.92-1.43) 0.216 1.16 (0.93-1.45) 0.184 1.12 (0.89-1.39) 0.342
Women
  Serum uric acid 1.07 (1.00-1.15) 0.040 1.09 (1.00-1.19) 0.044 1.14 (1.04-1.24) 0.003 1.14 (1.05-1.25) 0.002 1.12 (1.02-1.22) 0.016
  Hyperuricemia 1.41 (1.15-1.73) 0.001 1.43 (1.13-1.79) 0.003 1.43 (1.12-1.83) 0.004 1.45 (1.13-1.86) 0.003 1.36 (1.06-1.75) 0.016

图2

血尿酸与气流阻塞发病之间的相关性"

1 The Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2021 Report)[EB/OL]. (2020-11-07)[2021-02-13]. https://goldcopd.org/2021-gold-reports/.
2 Zhou MG , Wang HD , Zeng XY , et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394 (10204): 1145- 1158.
doi: 10.1016/S0140-6736(19)30427-1
3 Wang C , Xu JY , Yang L , et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): A national cross-sectional study[J]. Lancet, 2018, 391 (10131): 1706- 1717.
doi: 10.1016/S0140-6736(18)30841-9
4 Bowler RP , Barnes PJ , Crapo JD . The role of oxidative stress in chronic obstructive pulmonary disease[J]. COPD, 2004, 1 (2): 255- 277.
doi: 10.1081/COPD-200027031
5 Brajer B , Batura-Gabryel H , Nowicka A , et al. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression[J]. J Physiol Pharmacol, 2008, 59 (Suppl 6): 145- 152.
6 Cosio MG , Saetta M , Agusti A . Immunologic aspects of chronic obstructive pulmonary disease[J]. N Engl J Med, 2009, 360 (23): 2445- 2454.
doi: 10.1056/NEJMra0804752
7 Li X , Meng XR , Timofeeva M , et al. Serum uric acid levels and multiple health outcomes: Umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies[J]. BMJ, 2017, 358, j3799.
8 Holme I , Aastveit AH , Hammar N , et al. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417, 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)[J]. J Intern Med, 2009, 266 (6): 558- 570.
doi: 10.1111/j.1365-2796.2009.02133.x
9 Cao X , Wu LX , Chen ZH . The association between elevated serum uric acid level and an increased risk of renal function decline in a health checkup cohort in China[J]. Int Urol Nephrol, 2018, 50 (3): 517- 525.
doi: 10.1007/s11255-017-1732-6
10 Wattanachayakul P , Rujirachun P , Charoenngam N , et al. Chro-nic obstructive pulmonary disease (COPD) is associated with a higher level of serum uric acid. A systematic review and meta-analysis[J]. Adv Respir Med, 2020, 88 (3): 215- 222.
doi: 10.5603/ARM.2020.0119
11 Aida Y , Shibata Y , Osaka D , et al. The relationship between serum uric acid and spirometric values in participants in a health check: The Takahata study[J]. Int J Med Sci, 2011, 8 (6): 470- 478.
doi: 10.7150/ijms.8.470
12 Fukuhara A , Saito J , Sato S , et al. The association between risk of airflow limitation and serum uric acid measured at medical health check-ups[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12, 1213- 1219.
doi: 10.2147/COPD.S126249
13 Hong JW , Noh JH , Kim DJ . Association between serum uric acid and spirometric pulmonary function in Korean adults: The 2016 Korea National Health and Nutrition Examination Survey[J]. PLoS One, 2020, 15 (10): e0240987.
doi: 10.1371/journal.pone.0240987
14 杨兴华, 陶秋山, 孙凤, 等. 台湾地区35~74岁健康体检人群代谢综合征发病风险预测模型的建立[J]. 中华流行病学杂志, 2013, 34 (9): 874- 878.
doi: 10.3760/cma.j.issn.0254-6450.2013.09.004
15 Lin WY , Yao CA , Wang HC , et al. Impaired lung function is associated with obesity and metabolic syndrome in adults[J]. Obesity (Silver Spring), 2006, 14 (9): 1654- 1661.
doi: 10.1038/oby.2006.190
16 《中国高血压基层管理指南》修订委员会. 中国高血压基层管理指南(2014年修订版)[J]. 中国医学前沿杂志(电子版), 2015, 7 (7): 18- 40.
17 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38 (4): 292- 344.
18 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 血脂异常基层诊疗指南(实践版2019)[J]. 中华全科医师杂志, 2019, 18 (5): 417- 421.
doi: 10.3760/cma.j.issn.1671-7368.2019.05.004
19 Levey AS , Stevens LA , Schmid CH , et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150 (9): 604- 612.
doi: 10.7326/0003-4819-150-9-200905050-00006
20 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 痛风及高尿酸血症基层诊疗指南(实践版2019)[J]. 中华全科医师杂志, 2020, 19 (6): 486- 494.
21 Chen CY , Lv JM , Yao QZ . Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: An overview[J]. Med Sci Monit, 2016, 22, 2501- 2512.
doi: 10.12659/MSM.899852
22 Ciencewicki J , Trivedi S , Kleeberger SR . Oxidants and the pathogenesis of lung diseases[J]. J Allergy Clin Immunol, 2008, 122 (3): 456- 468.
doi: 10.1016/j.jaci.2008.08.004
23 Tuder RM , Zhen LJ , Cho CY , et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade[J]. Am J Respir Cell Mol Biol, 2003, 29 (1): 88- 97.
doi: 10.1165/rcmb.2002-0228OC
24 Ruggiero C , Cherubini A , Miller E , et al. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years[J]. Am J Cardiol, 2007, 100 (1): 115- 121.
doi: 10.1016/j.amjcard.2007.02.065
25 冯思玮, 马万里, 熊亮. 血尿酸在慢性阻塞性肺疾病患者中临床意义的Meta分析[J]. 中国临床研究, 2020, 33 (1): 35- 44.
26 Horsfall LJ , Nazareth I , Petersen I . Serum uric acid and the risk of respiratory disease: A population-based cohort study[J]. Thorax, 2014, 69 (11): 1021- 1026.
doi: 10.1136/thoraxjnl-2014-205271
27 Palmer TM , Nordestgaard BG , Benn M , et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts[J]. BMJ, 2013, 347, f4262.
doi: 10.1136/bmj.f4262
28 Song JU , Hwang J , Ahn JK . Serum uric acid is positively associated with pulmonary function in Korean health screening examinees[J]. Mod Rheumatol, 2017, 27 (6): 1057- 1065.
doi: 10.1080/14397595.2017.1285981
29 Waring WS , Convery A , Mishra V , et al. Uric acid reduces exercise-induced oxidative stress in healthy adults[J]. Clin Sci (Lond), 2003, 105 (4): 425- 430.
30 Lu N , Dubreuil M , Zhang YQ , et al. Gout and the risk of Alzheimer' s disease: A population-based, BMI-matched cohort study[J]. Ann Rheum Dis, 2016, 75 (3): 547- 551.
31 Wang YF , Li JX , Sun XS , et al. High serum uric acid levels are a protective factor against unfavourable neurological functional outcome in patients with ischaemic stroke[J]. J Int Med Res, 2018, 46 (5): 1826- 1838.
32 Hu LH , Hu GP , Xu BP , et al. U-shaped association of serum uric acid with all-cause and cause-specific mortality in US adults: A cohort study[J]. J Clin Endocrinol Metab, 2020, 105 (1): e597- e609.
33 Lipovec NA , Beijers RJ , Borst B , et al. The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: A systematic review[J]. COPD, 2016, 13 (3): 399- 406.
34 Adnan E , Rahman IA , Faridin HP . Relationship between insulin resistance, metabolic syndrome components and serum uric acid[J]. Diabetes Metab Syndr, 2019, 13 (3): 2158- 2162.
[1] 王子恺,莫佳丽,张蒙,廖纪萍. 2013—2020年北京市慢性阻塞性肺疾病急性加重女性住院患者的流行病学和住院费用分析[J]. 北京大学学报(医学版), 2023, 55(6): 1074-1081.
[2] 祝春素,连至炜,崔一民. 中国中老年人抑郁和慢性病的关联[J]. 北京大学学报(医学版), 2023, 55(4): 606-611.
[3] 马涛,李艳辉,陈曼曼,马莹,高迪,陈力,马奇,张奕,刘婕妤,王鑫鑫,董彦会,马军. 青春期启动提前与儿童肥胖类型的关联研究: 基于横断面调查和队列调查[J]. 北京大学学报(医学版), 2022, 54(5): 961-970.
[4] 张学武. 痛风关节炎治疗中几个备受关注的问题[J]. 北京大学学报(医学版), 2021, 53(6): 1017-1019.
[5] 彭喆,丁亚敏,裴林,姚海红,张学武,唐素玫. 痛风患者发生关节及肌腱内晶体沉积的临床特点[J]. 北京大学学报(医学版), 2021, 53(6): 1067-1071.
[6] 朱敬先,鲁胜楠,蒋艳芳,姜玲,王健全. 老年肩袖损伤手术患者术前肺功能的影响因素[J]. 北京大学学报(医学版), 2021, 53(5): 902-906.
[7] 谢一帆,王昱,邓雪蓉,耿研,季兰岚,张卓莉. 影响双能CT尿酸盐结晶检出率的因素[J]. 北京大学学报(医学版), 2021, 53(2): 261-265.
[8] 王昱,邓雪蓉,季兰岚,张晓慧,耿研,张卓莉. 超声检测痛风患者肌腱受累的危险因素和诊断价值[J]. 北京大学学报(医学版), 2021, 53(1): 143-149.
[9] 张子一,夏斌,徐明明,李毅萍,唐瞻贵,陈泳清. 湖南韶山地区儿童口腔卫生干预效果评价[J]. 北京大学学报(医学版), 2020, 52(5): 913-918.
[10] 包海荣,刘晓菊,谭恩丽,舒娟,董继元,李盛. 兰州市气温和相对湿度对慢性阻塞性肺疾病患者门诊就诊人次的影响及其交互效应[J]. 北京大学学报(医学版), 2020, 52(2): 308-316.
[11] 谢江,李菲. 睡眠重叠综合征与糖尿病发病率的横断面调查研究[J]. 北京大学学报(医学版), 2019, 51(2): 252-255.
[12] 程吟楚,潘勇平,张洋,潘昱廷,丁呈怡,曹宇,卓琳,方任飞,高爱钰,郭晶,李爱军,付强,马军,詹思延. 北京市中学生药品安全认知与行为调查[J]. 北京大学学报(医学版), 2017, 49(6): 1038-1043.
[13] 余灿清,陈怡平,吕筠,郭彧,Paul Sherliker,卞铮,周汇燕,谭云龙,陈君石,陈铮鸣,李立明. 中国30~79岁成人抑郁障碍与冠心病和脑卒中的关联[J]. 北京大学学报(医学版), 2016, 48(3): 465-471.
[14] 许文敏, 张新霞, 伍贵富. 深圳市福田区22家社区健康服务中心高血压患者现状分析[J]. 北京大学学报(医学版), 2014, 46(6): 859-862.
[15] 刘淼, 何耀, 姜斌, 吴蕾, 王建华, 杨姗姗, 王义艳, 李小鹰. 北京某社区老年人群肱踝脉搏波传导速度与代谢综合征的现况研究[J]. 北京大学学报(医学版), 2014, 46(3): 429-434.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!